AYOXXA Biosystems, an international biotech company based in Cologne, Germany and Singapore has developed a proprietary technology platform for multiplexed protein analysis. Core to the cutting-edge system is a bead-based technology that yields 10,000-fold more data points than a standard ELISA. Together with the lowest sample volume in multiplex protein analysis history, very good accuracy and data robustness, high data throughput and readout with equipment existing already in your lab, AYOXXA will innovate biomedical research, pharmacological screening and preclinical diagnostics development. Its „in-situ encoded bead array“ (IEBA) technology allows industry and university users to realize the full potential of proteomics reliably as well as resource and cost efficiently.
AYOXXA stands for leveraging success in proteomics.